Authors
Latest:
Camping for HealthJackie Miller, BSN, RN, OCN, works to provide emotional support for children whose parents have cancer.
Latest:
Chronic Pain and Policy Restrictions: Controversies Holding Back Effective Pain ManagementPatients with cancer are faced with chronic pain that nurses often cannot manage properly due to outdated restrictions and practices.
Latest:
The Silenced Voice of the CaregiverFor oncology nurses, it is important to advocate for patients and families through ongoing assessments for caregiver burden, financial toxicity, and effective communication that lead to poor decision-making.
Latest:
Metformin May Decrease Diabetics' Breast Cancer RiskIn postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.
Latest:
Paula Raska Discusses Patient Navigation Through Cancer CarePaula Raska, a research associate from the Cleveland Clinic, discusses a study of patient navigation.
Latest:
Helping Patients Manage Work-Life Balance During and After TreatmentDuring and after treatment, the majority of patients will be back at their jobs sometime after diagnosis and treatment, but that doesn’t have to come with emotional distress if possible outcomes are discussed.
Latest:
New Discoveries in AML Treatments Bring HopeExpert Jeffrey Lancet, MD, discusses the emerging agents in treating acute myeloid leukemia (AML) and challenges that still exist for improving patient outcome.
Latest:
Mary Lou Woodford on CoC Accreditation ComplianceMary Lou Woodford, from the Cancer Resource Foundation, provides guidance on staying compliant with the new patient navigation accreditation standards from the American College of Surgeons Commission on Cancer.
Latest:
Oral Elacestrant Requires Patient Education in Metastatic ER+ Breast CancerNausea and upper GI discomfort are frequently linked with use of the oral SERD.
Latest:
Kathryn H. Schmitz Answers: What Can Mouse Studies Offer Human Research?Kathryn H. Schmitz, PhD, MPH, professor of Public Health Sciences and associate director of Population Sciences at the Penn State Cancer Institute, discusses benefits that can be reaped from running parallel mouse and human studies.
Latest:
Lung Cancer-5 Reasons to be HopefulThe month of May is Lung Cancer Hope Month, and here are just 5 reasons we can all be hopeful.
Latest:
Surviving the ERBeing a caregiver in the ER is usually pretty awful. It feels like I'm always in the way.
Latest:
Beth Sandy on Incorporating Amivantamab and Mobocertinib into Clinical Practice for Patients With EGFR Exon 20 Insertion NSCLCBeth Sandy, MSN, CRNP, discusses the application of 2 FDA approved drugs for patients with non–small cell lung cancer and an exon 20 insertion mutation.
Latest:
Cabozantinib/Atezolizumab Shows Promise in Treating Advanced HCCA combination of cabozantinib and atezolizumab improved the PFS in patients with Advanced HCC
Latest:
Expert Discusses the Present and Future of Genetic Testing in Breast CancerLaura J. van’t Veer, PhD, discussed determining more accurate methods of treatment for patients with early- and late-state breast cancer based on advances in genetic testing, specifically the 70-gene prognostic signature.
Latest:
Dr. Sutphen Discusses Insurance Coverage of Genetic Counseling and TestingRebecca Sutphen, MD, from the University of South Florida, discusses the importance of connecting patients with clinical trials.
Latest:
Disparities Exist in Younger Adults With GI CancersThere are socioeconomic and ethnic disparities in young adults who receive a diagnosis of colorectal and gastric cancers, according to Amir Khan, MD, from City of Hope.
Latest:
Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric CancerShared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
Latest:
Combinations May Combat PARP ResistanceCombining PARP inhibitors with another kind of agent may be key in overcoming resistance.
Latest:
Alix Beaupierre on Patient Education for CAR T-cell Therapy Clinical TrialsAlix Beaupierre, RN, BSN, OCN, Moffitt Cancer Center, explains the patient education program created for a recent CAR T-cell therapy clinical trial.
Latest:
Dr. Jessica Ryan on the Role of Nurses in Extreme OncoplastyJessica Ryan, MD, breast surgeon, Elliot Breast Health Center, Manchester, New Hampshire, discusses the role of oncology nurses in extreme oncoplasty.
Latest:
Patrick Spencer on Preparing Patients with Multiple Myeloma for Daratumumab TreatmentPatrick Spencer, RN, OCN provides important points to cover when counseling a patient with multiple myeloma receiving treatment with daratumumab.
Latest:
Mark Lazenby on Psychosocial Topics Concerning APOSMark Lazenby, PhD, APRN, FAPOS, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses psychosocial topics that concern APOS.
Latest:
Enhancing Peer Review to Support APN PracticeYale-New Haven Hospital (YNHH) currently credentials more than 400 advanced practice nurses (APNs) who practice in a wide range of roles and geographic locations. The number of practitioners more than doubled in the past 3 years, and now more than 50 APNs are practicing in oncology in Smilow Cancer Hospital at YNHH and at community care centers.
Latest:
Christian Capitini on Response to ImmunotherapyChristian Capitini discusses the responses to immunotherapy.
Latest:
Nurses Can Lead the Management of GI ToxicitiesNurses can lead the healthcare team when it comes to managing immune-related GI toxicities.
Latest:
Claire Friedman on Considerations for Older Patients Receiving ImmunotherapyClaire Friedman discusses the factors clinicians should consider when determining an immunotherapy treatment plan for older patients.
Latest:
Dr. Shuo Ma Discusses Side Effects from New Treatments in NHLShuo Ma, MD, PhD, assistant professor at Northwestern University in the Robert H. Lurie Comprehensive Cancer Center, discusses some of the side effects that come with new agents approved for the treatment of non-Hodgkin Lymphoma.
